NCT03077620View on ClinicalTrials.gov

Sleep Quality and Amyloid-Beta Kinetics

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 28, 2021

Study Completion Date

March 30, 2021

Conditions
Amyloid-beta
Interventions
DRUG

Suvorexant

Participants will be given a sleep aid (10mg or 20mg suvorexant) at bedtime for two consecutive nights that they are spending in a research unit.

DRUG

Placebo

Participants will be given a placebo at bedtime for two consecutive nights that they are spending in a research unit.

Trial Locations (1)

63144

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03077620 - Sleep Quality and Amyloid-Beta Kinetics | Biotech Hunter | Biotech Hunter